May 9, 2019 / 4:15 PM / 2 months ago

BRIEF-Polyphor Temporarily Halts Enrollment In Phase III Studies Of Murepavadin

May 9 (Reuters) - Polyphor AG:

* POLYPHOR TEMPORARILY HALTS ENROLLMENT IN PHASE III STUDIES OF MUREPAVADIN FOR TREATMENT OF PATIENTS WITH NOSOCOMIAL PNEUMONIA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below